Which has the lower trailing P/E, AZN or LLY?

AZN has the lower trailing P/E: AZN trades at 12.77 and LLY at 42.54. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, AZN or LLY?

Over the past five years, LLY grew revenue faster — AZN at a 16.99% CAGR versus LLY at 23.17%.

Does AZN or LLY pay a bigger dividend?

AZN yields 1.89% and LLY yields 0.54% based on trailing dividends and the latest price.

Is AZN or LLY more profitable?

LLY runs the higher net margin — AZN at 17.19% versus LLY at 34.98%.

How have AZN and LLY total returns compared?

Over the past 10 years, AZN delivered 13.96% and LLY delivered 32.66% annualized total return. Past performance doesn't predict future results.

AstraZeneca PLC (AZN) vs Eli Lilly and Company (LLY)

A side-by-side comparison of AstraZeneca PLC and Eli Lilly and Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

AZN

AstraZeneca PLC

$133.67B

$172.48HealthcareDelayed quote: Jul 28, 2026, 7:53 PM EDT

LLY

Eli Lilly and Company

$1.15T

$1,222.61HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

Total return — AZN vs LLY

growth of $100 · dividends reinvested · last 30y

AZN +2029.9%LLY +8631.2%LLY compounded faster

AZN LLY

AZN vs LLY: by the numbers

•LLY is the larger company ($1.15T vs $133.67B market cap).
•AZN trades at the lower trailing earnings multiple (12.77 vs 42.54 P/E), one valuation lens rather than an overall verdict.
•LLY converts more revenue to profit (34.98% vs 17.19% net margin).
•LLY grew revenue faster over the past five years (23.17% vs 16.99% CAGR).
•AZN pays the higher dividend yield (1.89% vs 0.54%).

Metrics side by side

Valuation

Metric	AZN	LLY
P/E ratio	12.77	42.54
Forward P/E	16.58	34.10
P/S ratio	2.19	14.85
P/B ratio	2.80	34.39
PEG ratio	0.29	0.49
EV / EBITDA	7.89	31.98
FCF yield	6.09%	1.27%

Profitability

Metric	AZN	LLY
Gross margin	81.68%	83.51%
Operating margin	23.69%	45.87%
Net margin	17.19%	34.98%
ROE	21.95%	81.01%
ROIC	13.03%	30.20%

Dividends

Metric	AZN	LLY
Dividend yield	1.89%	0.54%
Payout ratio	24.24%	28.09%

Growth (annualized)

Metric	AZN	LLY
Revenue CAGR (5Y)	16.99%	23.17%
EPS CAGR (5Y)	22.02%	28.88%
FCF CAGR (5Y)	15.68%	19.54%
Total return CAGR (5Y)	10.56%	38.81%

Frequently asked

Which has the lower trailing P/E, AZN or LLY?: AZN has the lower trailing P/E: AZN trades at 12.77 and LLY at 42.54. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, AZN or LLY?: Over the past five years, LLY grew revenue faster — AZN at a 16.99% CAGR versus LLY at 23.17%.
Does AZN or LLY pay a bigger dividend?: AZN yields 1.89% and LLY yields 0.54% based on trailing dividends and the latest price.
Is AZN or LLY more profitable?: LLY runs the higher net margin — AZN at 17.19% versus LLY at 34.98%.
How have AZN and LLY total returns compared?: Over the past 10 years, AZN delivered 13.96% and LLY delivered 32.66% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AZN analysis Full LLY analysis Interactive comparison tool

Dig into the metrics

AstraZeneca P/E ratio Eli Lilly and P/E ratio AstraZeneca dividend yield Eli Lilly and dividend yield AstraZeneca ROE Eli Lilly and ROE AstraZeneca operating margin Eli Lilly and operating margin AstraZeneca revenue growth Eli Lilly and revenue growth AstraZeneca free cash flow Eli Lilly and free cash flow

AstraZeneca & Eli Lilly and appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.